Alterity Therapeutics Ltd.ASX: ATH

Alterity Receives Positive FDA Feedback From Type C Meeting

Mar 30, 2026 at 3:18 AM UTC · Issued by Alterity Therapeutics Ltd.

Alterity Therapeutics Ltd has released a press release.

View Attachment